Skip to content

The Effect of an Online Plant-Based Dietary Program on Cardiovascular Risk Factors in Persons with Type 2 Diabetes Mellitus: A Randomized Controlled Trial

The Effect of an Online Plant-Based Dietary Program on Cardiovascular Risk Factors in Persons with Type 2 Diabetes Mellitus: A Randomized Controlled Trial - Plate-DM

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON51514
Enrollment
140
Registered
2022-09-21
Start date
2022-11-29
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes diabetes mellitus

Interventions

a 12-week plant-based dietary program consisting of information via an online platform, guidance by dieticians and peer support groups. Patients will aim to maximize their intake of plant-based prod

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosis of Type 2 Diabetes sinds at least 1 year and using oral glucose-lowering medication 2. If using lipid-lowering and/or blood pressure-lowering medication than on a stable dose for at least 2 months before the screening. 3. Age of 18 years or older on the day of signing the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Hypoglycemia unawareness 2. 2 or more episodes of severe hypoglycemia during last 3 months 3. uncontrolled hypertension or diabetes 4. vitamin B12 or iron deficiency

Design outcomes

Primary

MeasureTime frame
A blinded intention-to-treat analysis of the endpoint will be conducted. The primary outcomes of this study are change in HbA1c and change in estimated relative CVD risk (based on change in LDL-c, SBP and HbA1c) after 12 weeks of intervention.

Secondary

MeasureTime frame
Secondary outcomes of will be measures of glycemic control (HOMA2-IR, HOMA2-B%, TyG-index, NAFLD Score), lipoprotein profile (LDL cholesterol, apolipoprotein B, non-HDL cholesterol, HDL cholesterol), inflammation, blood pressure, quality of life, anthropometric measurements (BMI, hip/waist ratio) and adherence to the dietary intervention will be assessed using a dietary index. Lastly, the effect of the adherence and diabetes subtype (e.g. insulin-resistant or insulin deficient) on these outcomes will be quantified and barriers and factors supporting adherence will be identified.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)